TNXP

Tonix Pharmaceuticals Holding Corp. (TNXP) is a biopharmaceutical company headquartered in Chatham, New Jersey, dedicated to developing innovative treatments for central nervous system disorders and rare diseases. With a focus on addressing significant unmet medical needs in mental health and pain management, Tonix is advancing a diverse pipeline of proprietary drug candidates through various phases of clinical development. The company's strengths in drug formulation and delivery, along with its strategic emphasis on its clinical programs, position Tonix as a potential leader in the pharmaceutical landscape, poised for significant growth amid evolving healthcare demands.